Chen B, Basil J B, Schefft G L, Cole F S, Sadovsky Y
Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri, USA.
Am J Perinatol. 1997 Mar;14(3):171-6. doi: 10.1055/s-2007-994121.
To determine whether antenatal corticosteroid administration after midtrimester premature rupture of membranes (PROM) reduces the incidence or severity of neonatal intraventricular hemorrhage, we identified a cohort of infants delivered between 24 to 28 weeks gestation (n = 75) by mothers with PROM. Information was obtained from a computerized database (n = 3716) of all newborns admitted to the neonatal intensive care unit at a single medical center from 1991 to 1996. We reviewed records of each mother-infant pair to determine antenatal corticosteroid administration, presence, and severity of neonatal intraventricular hemorrhage, and frequency of infectious complications. Using a logistic regression model, antenatal corticosteroid administration was associated with a significantly reduced risk of severe (grade 3-4) intraventricular hemorrhage (0.1 odds ratio, 0.006-0.57, 95% confidence interval), but not a reduced incidence of intraventricular hemorrhage (grade 1-4, 0.4 odds ratio, 0.12-1.05, 95% confidence interval).
为了确定孕中期胎膜早破(PROM)后给予产前皮质类固醇激素是否会降低新生儿脑室内出血的发生率或严重程度,我们确定了一组由胎膜早破母亲分娩的妊娠24至28周的婴儿(n = 75)。信息来自1991年至1996年在单一医疗中心新生儿重症监护病房收治的所有新生儿的计算机数据库(n = 3716)。我们查阅了每对母婴的记录,以确定产前皮质类固醇激素的使用情况、新生儿脑室内出血的存在情况和严重程度以及感染并发症的发生频率。使用逻辑回归模型,产前使用皮质类固醇激素与严重(3 - 4级)脑室内出血风险显著降低相关(优势比0.1,95%置信区间0.006 - 0.57),但与脑室内出血发生率降低无关(1 - 4级,优势比0.4,95%置信区间0.12 - 1.05)。